跳至主要内容
临床试验/JPRN-jRCTs051210100
JPRN-jRCTs051210100已完成2 期

Multi-institutional Phase IIa Trial of Postoperative Chemoradiotherapy Using Hyperfractionated Intensity-modulated Radiotherapy and Weekly Cisplatin in High Risk Patients with Head and Neck Squamous Cell Carcinoma.

Mizowaki Takashi0 个研究点目标入组 10 人开始时间: 2021年10月6日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

Postoperative chemoradiotherapy using hyperfractionation in IMRT was feasible for high-risk patients with head and neck squamous cell carcinoma.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 80age old(—)
性别
All

入选标准

  • •1. Tumor histology is confirmed as squamous cell carcinoma by surgically resected specimen.
  • •2. Patients with oral, oropharyngeal, hypopharyngeal, or laryngeal carcinoma.
  • •3. Patients detected either or both of i) and ii) by primary tumor resection and neck dissection.
  • •i) Positive microscopic excisional margin.
  • •ii) Extracapsular extension of cervical lymph node.
  • •4. Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1.

排除标准

  • •Patients with p16 positive oropharyngeal carcinoma.

研究者

发起方
Mizowaki Takashi

相似试验

Multi-institutional Phase IIa Trial of Postoperative... | 临床试验